APT Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	3,058	2,568	2,049	1,642	1,204	822.86
Other Revenue	16.41	16.41	16.62	8.49	11.55	5.82
Revenue	3,075	2,584	2,066	1,650	1,216	828.69
Revenue Growth	27.66%	25.08%	25.18%	35.71%	46.74%	72.85%
Cost of Revenue	836.52	707.39	579.89	486.14	354.04	259.08
Gross Profit	2,238	1,877	1,486	1,164	861.98	569.61
Selling, General & Admin	629.87	579.25	464.34	386.96	307.57	251.43
Research & Development	424.91	364.8	290.54	237.92	174.88	134.88
Other Operating Expenses	49.45	28.18	15.22	14.52	13.75	8.14
Operating Expenses	1,119	988.53	772.32	639.21	496.99	393.93
Operating Income	1,119	888.01	713.59	524.86	364.99	175.68
Interest Expense	-1.39	-1.46	-2.01	-3.69	-1.45	-1.63
Interest & Investment Income	41.59	30.73	25.23	27.74	23.94	13.26
Currency Exchange Gain (Loss)	-5.3	-5.3	2.83	2.66	1.17	-1
Other Non Operating Income (Expenses)	-14.27	-0.83	-0.82	-0.04	-0.49	-0.5
EBT Excluding Unusual Items	1,139	911.16	738.83	551.53	388.16	185.81
Impairment of Goodwill	-	-	-	-3.84	-	-
Gain (Loss) on Sale of Investments	2.69	0.49	-16.7	-	0.34	21.72
Gain (Loss) on Sale of Assets	-0.22	-0.93	0.25	11.97	0.06	0.02
Asset Writedown	-4.21	-1.85	-0.83	-0.12	-10.68	-3.57
Other Unusual Items	25.42	27.43	24.42	36.83	17.25	17.58
Pretax Income	1,163	936.29	745.97	596.37	395.13	221.55
Income Tax Expense	163.95	128.55	87.8	74.24	54.98	26.7
Earnings From Continuing Operations	998.98	807.74	658.17	522.13	340.16	194.85
Minority Interest in Earnings	16.57	12.9	14.98	11.79	17.86	13.07
Net Income	1,016	820.64	673.15	533.92	358.02	207.92
Net Income to Common	1,016	820.64	673.15	533.92	358.02	207.92
Net Income Growth	32.18%	21.91%	26.08%	49.13%	72.19%	87.70%
Shares Outstanding (Basic)	140	141	140	140	140	137
Shares Outstanding (Diluted)	140	141	141	142	142	138
Shares Change	-1.05%	0.05%	-0.27%	-0.16%	2.99%	31.45%
EPS (Basic)	7.27	5.82	4.80	3.82	2.56	1.52
EPS (Diluted)	7.25	5.80	4.76	3.77	2.52	1.51
EPS Growth	33.58%	21.85%	26.41%	49.38%	67.20%	42.79%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	1,061	682.17	93.15	487.03	224.25	14.01
Free Cash Flow Per Share	7.58	4.82	0.66	3.44	1.58	0.10
Dividend Per Share	1.000	1.000	1.207	0.951	0.785	0.476
Dividend Growth	-17.14%	-17.14%	26.88%	21.20%	65.01%	100.00%
Gross Margin	72.79%	72.62%	71.93%	70.54%	70.88%	68.74%
Operating Margin	36.38%	34.37%	34.54%	31.81%	30.01%	21.20%
Profit Margin	33.03%	31.76%	32.58%	32.36%	29.44%	25.09%
Free Cash Flow Margin	34.51%	26.40%	4.51%	29.51%	18.44%	1.69%
EBITDA	1,236	988.48	790.98	580.9	405.69	203.49
EBITDA Margin	40.22%	38.26%	38.29%	35.20%	33.36%	24.56%
D&A For EBITDA	117.79	100.47	77.38	56.04	40.7	27.81
EBIT	1,119	888.01	713.59	524.86	364.99	175.68
EBIT Margin	36.38%	34.37%	34.54%	31.80%	30.01%	21.20%
Effective Tax Rate	14.10%	13.73%	11.77%	12.45%	13.91%	12.05%
Revenue as Reported	3,075	2,584	2,066	1,650	1,216	828.69